Literature DB >> 2938649

Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry.

C S Ramesha, W C Pickett.   

Abstract

A very sensitive method of 1-O-alkyl-2-acetyl-sn-glycerophosphocholine (platelet activating factor) quantitation is described. 1-O-Alkyl-2-acetyl-sn-glycerophosphocholine is converted to 1-O-alkyl-2-acetylglycerol by treating with phospholipase-C which is in turn acylated with pentaflurobenzoyl chloride. The resulting diglyceryl ester of pentafluorobenzene is analysed by gas chromatography/negative ion chemical ionization mass spectrometry. With methane as the reagent gas the pentafluorobenzoyl acyl derivative yields mainly the molecular anion ([M]-.) representing more than 92% of the total ion current. Deuterium-labeled 1-O-hexadecyl-2-(2H3)acetyl-sn-glycerophosphocholine is used as the internal standard for quantitation. The standard curves are linear and typically have a correlation coefficient of greater than 0.999. Using 1 pg of the deuterium-labeled internal standard, quantities as low as 100 fg are measured.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938649     DOI: 10.1002/bms.1200130302

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  10 in total

1.  Mass spectrometric analysis of platelet-activating factor after isolation by solid-phase extraction and direct derivatization with pentafluorobenzoic anhydride.

Authors:  S T Weintraub; R K Satsangi; E A Sprague; T J Prihoda; R N Pinckard
Journal:  J Am Soc Mass Spectrom       Date:  2000-02       Impact factor: 3.109

2.  1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes.

Authors:  K Satouchi; M Oda; K Saito
Journal:  Lipids       Date:  1987-04       Impact factor: 1.880

3.  Synthesis of trideuterated O-alkyl platelet activating factor and lyso derivatives.

Authors:  C Prakash; S Saleh; D F Taber; I A Blair
Journal:  Lipids       Date:  1989-09       Impact factor: 1.880

4.  Metabolism of platelet-activating factor in isolated perfused rat lung.

Authors:  P E Haroldsen; N F Voelkel; J E Henson; P M Henson; R C Murphy
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

5.  Platelet-Activating Factor Quantification Using Reversed Phase Liquid Chromatography and Selected Reaction Monitoring in Negative Ion Mode.

Authors:  Daniel P Pike; Celine L Hartman; Gregory J Weissler; Elisa N D Palladino; Carolyn J Albert; David A Ford
Journal:  Lipids       Date:  2016-10-18       Impact factor: 1.880

6.  Identification and quantitation of PAF from psoriatic scales.

Authors:  C S Ramesha; N Soter; W C Pickett
Journal:  Agents Actions       Date:  1987-08

7.  Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage.

Authors:  F H Chilton; M Patel; A N Fonteh; W C Hubbard; M Triggiani
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

8.  A specific, sensitive and high-capacity immunoassay for PAF.

Authors:  B A Baldo; M A Smal; A C McCaskill
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

9.  Novel mass spectral fragmentation of heptafluorobutyryl derivatives of acyl analogues of platelet-activating factor.

Authors:  S T Weintraub; R N Pinckard; T G Heath; D A Gage
Journal:  J Am Soc Mass Spectrom       Date:  1991-12       Impact factor: 3.109

10.  Antigen-induced generation of lyso-phospholipids in human airways.

Authors:  F H Chilton; F J Averill; W C Hubbard; A N Fonteh; M Triggiani; M C Liu
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.